PORCN Inhibitor Report

By www.marketscagr.com

Report Details

Report Name

Global PORCN Inhibitor Market Growth 2024-2030 Story

Pages

122

Price

$ 3660

Features

PORCN Inhibitor Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              "Mitsubishi Tanabe Pharma"|||"AB Science"|||"Redx Pharma"|||"Merck"|||"R&D Systems"|||"APExBIO Technology"|||"MedChemExpress"|||"Selleck Chemicals"|||"REPROCELL"|||"Glixx Laboratories"|||"TargetMol"|||"Santa Cruz Biotechnology"|||"Cayman Chemical"|||"Tocris Bioscience"|||"Abcam"            

Countries Covered

              "United States"|||"China"|||"Canada"|||"Mexico"|||"Brazil"|||"Japan"|||"Korea"|||"Southeast Asia"|||"India"|||"Australia"|||"Germany"|||"France"|||"UK"|||"Italy"|||"Russia"|||"Egypt"|||"South Africa"|||"Israel"|||"Turkey"|||"GCC Countries"            

Regions Covered

              global            

Prices

Single User License:

$ 3660

Multi User License:

$ 5490

Enterprise/Corporate User License:

$ 7320